Unknown

Dataset Information

Does omalizumab increase the risk of malignancy? A retrospective case-control study in a single tertiary hospital.


ABSTRACT:

SUBMITTER: Kim HJ 

PROVIDER: S-EPMC10932485 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature